Introduction: To compare the measured dose distributions to calculated ones in dose-to-water (D w ) and dose-to-medium (D m ) reporting modes for simple plans and patient-specific intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) plans using ArcCHECK with a fixed phantom density. Methods: The recommended density value of 1.18 g/cm 3 for Acuros XB and X-ray voxel Monte Carlo was assigned to Arc-CHECK on CT images. A total of 45 simple plans, including a 1-field plan, a 3-field plan, a 4-field plan, a half-arc plan from 270˚ to 90˚, and a full-arc plan, were assessed. Subsequently, the patient-specific 96 IMRT and VMAT plans were evaluated. Gamma analysis with a 3% normalized global dose error and a 3 mm distance-to-agreement criteria (γ3%G/3mm) was performed in 
Introduction
Worldwide, intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) are routinely used in clinical practice. These techniques have improved patient outcomes compared with three-dimensional (3D) conformal radiotherapy [1] [2] .
The multi-leaf collimator (MLC), gantry position, and/or dose rate vary continuously during IMRT and VMAT delivery. Such complicated beam delivery techniques lead to dosimetric differences between measurements and calculations; therefore, patient-specific quality assurance (QA) is required to validate the calculated dose distribution [3] . Patient-specific QA procedures differ from traditional approaches using an ionization chamber and films to two-dimensional (2D) planar or 3D volumetric dosimeters. One of the advantages of 3D volumetric dosimetry over 2D planar dosimetry is that volumetric dose distributions can be assessed with a single measurement. Dose calculation algorithms have evolved dramatically from measurementbased to model-based, linear Boltzmann transport equation (LBTE)-based, and Monte Carlo (MC)-based methods. Model-based algorithms, such as superposition/convolution algorithms, anisotropic analytic algorithms (AAA), and collapsed cone convolution/superposition (CCCS), provide more accurate results in low-density areas than measurement-based algorithms. The model-based calculation algorithm computes transport and dose deposition using radiological and density scaling deposited by the absorbed dose in water. LBTE-and MC-based dose calculation algorithms, such as Acuros XB (AXB) and X-ray voxel Monte Carlo (XVMC), respectively, are more accurate in heterogeneous regions than model-based dose calculation algorithms [4] - [16] . As a feature of the AXB and XVMC, these algorithms can calculate different dose reporting modes in water [dose-to-water (D w )] and in medium [dose-to-medium (D m )] through the stopping power ratio of water-to-medium [8] [13] [17] .
Recently, ArcCHECK (Sun Nuclear Corp., Melbourne, FL), which is one of the 3D volumetric dosimeters, has been clinically used as a patient-specific QA tool. Several studies on ArcCHECK have been reported with a focus on angular, directional, and field size dependencies, and response to scattering and leakage radiations in a fixed arc [18] - [24] . In these reports, patient-specific QA using ArcCHECK was also performed with AAA or CCCS algorithms [18] - [24] . Eaton et al. reported the comparison of measured dose distributions and calculated ones with several dose calculation algorithms, including MC-based method, by use of ArcCHECK. However, the report makes no mention of dose reporting modes in MC-based method [25] . The dose distribution between D w and D m was different in the "water-unlike" tissues with densities, due to the difference in stopping power ratio and fluence [8] . Taken together, a comparison between measured and calculated dose distributions in D w and D m using ArcCHECK were not fully elucidated. Before clinical implementation of ArcCHECK for IMRT and VMAT plans, qualified medical physicists should familiarize themselves with its characteristics against dose calculation algorithms.
The purpose of this study was to compare measured dose distributions and calculated ones in D w and D m in simple, patient-specific IMRT and VMAT plans using ArcCHECK with the fixed phantom density recommended by the vendor.
Materials and Methods

ArcCHECK Device
ArcCHECK is a cylindrical polymethylmethacrylate (PMMA) phantom with a 
Absolute Dose Calibration
A water tank (WP1D Water Phantom; IBA Dosimetry GmbH, Germany) was used to measure the absolute dose at a calibration depth of 3.3 cm according to the guidelines provided by Sun Nuclear Corporation (SNC) [25] . The physical distance from the top surface of the ArcCHECK to the diode detectors was 2.85 cm, which corresponds to a water-equivalent depth of 3.3 cm, as described above.
Before measuring the dose at the calibration depth of 3.3 cm in water, the dose per monitor unit (D/MU) was measured using the ionization chamber (PTW30013; PTW Co., Freiburg, Germany) annually calibrated by the Japan calibration service system. The chamber was irradiated perpendicular to the beam axis with a radiation field size of 10 × 10 cm 2 at a depth of 10 cm in water. The center of the ionization chamber was at a source-axis-distance of 100 cm. The dose delivered at the given depth was calculated by multiplying the delivered monitor unit, D/MU, and the tissue maximum ratio. Thereafter, the doses were measured at a depth of 3.3 cm and a source-surface distance of 86.3 cm in water,
according to SNC instructions [25] . The effective point of the measurement of the ionization chamber was located at the measuring depth. The absolute dose was corrected by D/MU and a displacement correction factor.
Measurements were performed on four treatment machines, including a Clinac 
ArcCHECK Phantom-Mass-Density
The computed tomography (CT) dataset of the ArcCHECK was provided from SNC for dose calculations. The user manual recommended that the ArcCHECK phantom-mass-density should be assigned a density close to that of the PMMA material for the treatment planning system (TPS) dose calculation [25] . The recommended density value of 1.18 g/cm 3 for LBTE-and MC-based dose calculation algorithms (e.g., AXB and XVMC), was assigned to the ArcCHECK on CT images. The density value of 1.18 g/cm 3 for AXB and XVMC was the combination of cartilage and bone density in TPS. 
Dosimetric Evaluation for Simple Plans
A total of 45 simple plans, including the 1-field anterior-posterior direction (1F), the 3-field anterior and left-right direction (3F), the 4-field anterior-posterior and left-right direction (4F), a half-arc delivery (half-arc) from 270˚ to 90˚ gantry angle under clockwise rotation, and a full-arc delivery (full-arc) from 181˚ to 179˚ gantry angle under clockwise rotation, were assessed. A field size of 10 × 10 cm 2 was used for all simple plans. The dose distributions were assessed quantitatively by gamma analysis with a 3% normalized global dose error and a 3-mm DTA threshold (γ3%G/3mm) criterion using SNC software (ver. 6.6) for all plans.
Dosimetric Evaluation for Patient-Specific Plans
A total of 96 patients were assessed retrospectively in this study. Of them, QA for 76 plans was conducted at Kyoto University Hospital and 20 at Osaka Red
Cross Hospital. Eighty-five patients were irradiated with VMAT by Varian machines; static IMRT by Vero was used for the remaining 11 patients. This study was approved by institutional review board. A summary of treatment machines, energy, delivery technique, and representative disease site is given in Table 2 . 
Results
Absolute Dose Calibration
The differences between the measured dose at a depth of 2.85 cm in ArcCHECK and the calculated dose at a depth of 3.3 cm in the water phantom were within ±1.0% for any combination in D w and D m .
Dosimetric Evaluation for Simple Plans
A summary of the γ3%G/3mm for simple plans is presented in Figure 1 . The median values of γ3%G/3mm for all simple plans, including 1F, 3F, 4F, half-arc, and full-arc, in D w and D m were 98.1% (range, 75.2% -100%) and 95.5% (range, 23.7% -100%), respectively. The median pass rates of γ3%G/3mm for all simple plans in D w were significantly higher than those in D m (p < 0.01).
Dosimetric Evaluation for Patient-Specific Plans
The pass rates of γ3%G/3mm in D w were significantly higher than those in D m . 
Discussion
The present study is the first reported to assess the comparison between measured dose distributions and calculated ones in D w and D m using ArcCHECK for various plans. We found that the median pass rates of γ3%G/3mm for all simple plans in D w were significantly higher than those in D m (Figure 1 ). In addition, the dose distribution calculated in D w agreed with the measured one to a high level of significance, compared with those in D m (Figure 2 ). AAPM TG 119 reported that the average percentage of γ3%G/3mm for IMRT was 96.3% ± 4.4% (mean ± 2σ [σ, standard deviation]) [26] . In addition, several studies have reported pass rates of around 95% with γ3%G/3mm using ArcCHECK [18] - [24] [27]. In this study, the median pass rate of γ3%G/3mm was 98.6% in D w , which is supported by previous reports.
Worldwide, the traceability of QA dosimetry is established in water; therefore, dose calibration protocols for treatment machines and treatment planning those for AAA and CCCS [17] . Therefore, the γ3%G/3mm of our results calculated in D w were consistent with those calculated in AAA and CCCS in the previous studies [18] - [24] .
The possibility, at first provided by Monte Carlo simulation, of reporting the dose as D m , has still become a subject of controversy in medical physics commu- should be assigned to the ArcCHECK on CT images. Note that, however, this density assignment is not recommended by SNC [25] .
The cause of lower γ3%G/3mm in D m may be due to ( ) Disease heterogeneity, included in this study, and characteristics of γ3%G/3mm would be causes of large variations between the results in D w and those in Dm.
As shown in the results of the 10FFF-MV X-ray in Figure 3 (a) and Vero in Figure 3(c) , the variations were almost the same between D w and D m due to disease homogeneity. However, larger variations were observed for other results, which would be derived from the characteristics of γ3%G/3mm. The concept of the gamma evaluation method combines the dose difference criterion with a DTA criterion for each point of interest [28] . If a global dose difference of <D% and/or DTA of <d-mm is observed, the gamma value at D%G/d-mm passes at the point of interest. In this study, local γ failure points in the high dose regions were observed ( Figure 4) ; however, γ3%G/3mm passed in the lower dose re-gions regardless of the dose level decrease in D m . At these points, the DTA would be within 3 mm although the dose differences were greater than 3%. Consequently, the characteristics of γ3%G/3mm were notable for subgroups including various diseases, which may lead to large variations in γ3%G/3mm calculated in D m .
Conclusion
This study demonstrated that measured dose distributions and calculated ones in D w agreed well with each other, and showed a greater agreement than those in D m for a range of energies, delivery techniques, and treatment machines from different institutions. From the viewpoint of the rationale of dosimetry, D w shows better agreement with measured dose distribution when using the fixed phantom density recommended by the vendor.
